Behind the staggering statistic that one in four Americans used illicit drugs in the past year lies a global crisis of addiction and loss, as revealed by data showing everything from the 107,941 overdose deaths in the U.S. to the $740 billion annual economic toll.
Key Takeaways
- In 2021, approximately 70.4 million people aged 12 or older (25.0% of the U.S. population) used illicit drugs in the past year
- Worldwide, an estimated 296 million people used drugs in 2021, which is 5.8% of the global adult population
- In the United States, marijuana was the most commonly used illicit drug in 2022, with 18.7% of people aged 12+ reporting past-year use
- Drug overdose deaths in the U.S. reached 107,941 in 2022, a 4% increase from 2021
- Opioids were involved in 81,806 overdose deaths in the U.S. in 2022
- Fentanyl and synthetic opioids caused 73,838 deaths in the U.S. in 2022
- The economic cost of drug abuse in the U.S. was $740 billion annually in lost productivity, healthcare, and criminal justice
- Opioid crisis cost U.S. states $1.02 trillion from 2017-2022 in economic burden
- Global illicit drug trade valued at $650 billion in 2022
- U.S. adults aged 18-25 had the highest past-year illicit drug use rate at 39.3% in 2021
- Males are 1.5 times more likely than females to use illicit drugs in the U.S.
- Among U.S. adolescents aged 12-17, Native Americans had 19.6% past-year illicit drug use in 2021, highest rate
- In 2021, 2.0 million U.S. people aged 12+ received treatment for SUD at specialty facility
- Only 10.4% of U.S. people with SUD received any treatment in 2021
- Medication-assisted treatment (MAT) reached 1.2 million with OUD in U.S. 2021
Drug abuse is a widespread global epidemic with devastating human and economic costs.
Demographics
1U.S. adults aged 18-25 had the highest past-year illicit drug use rate at 39.3% in 2021
Verified2Males are 1.5 times more likely than females to use illicit drugs in the U.S.
Verified3Among U.S. adolescents aged 12-17, Native Americans had 19.6% past-year illicit drug use in 2021, highest rate
Verified4Urban U.S. residents had higher drug use rates (25.4%) than rural (22.1%) in 2021
Directional5U.S. adults with less than high school education had 30.1% past-year drug use vs. 21.4% college grads
Single source6Globally, males comprise 75% of people in treatment for drug use disorders
Verified7In U.S., 16.5% of unemployed adults used illicit drugs past year vs. 22.4% full-time employed
Verified8African Americans in U.S. had 23.8% past-year marijuana use rate in 2021
Verified9LGBTQ+ youth report 40% higher substance use rates than heterosexual peers
Directional10In Europe, 15-24 year olds have highest cannabis use at 17% past-year prevalence
Single source11U.S. poor income (<100% FPL) had 28.5% drug use rate vs. high income 23.1% in 2021
Verified12Women in U.S. with children under 18 had higher prescription misuse rates (8.2%)
Verified13Hispanic U.S. adults had 25.6% past-year illicit drug use in 2021
Verified14Military veterans have 11% lifetime drug use disorder rate vs. 5% civilians
Directional15In Australia, Indigenous people have 3x higher illicit drug use rates than non-Indigenous
Single source16U.S. young adults 18-25 had 13.3% marijuana use disorder rate in 2021
Verified17Transgender individuals report 2x higher drug use rates for coping with discrimination
Verified18Rural U.S. adolescents had higher prescription opioid misuse (9.4%) than urban (5.2%)
Verified19In Canada, 25-34 year olds had highest opioid use disorder rates at 3.1%
Directional20U.S. divorced/widowed adults had 29.4% drug use vs. 23.5% married
Single source21Asian Americans lowest U.S. drug use rate at 15.2% past-year in 2021
Verified22Pregnant U.S. women had 5.4% illicit drug use rate in past month 2021
Verified23College students U.S. binge drink + drug use at 25% rate
Verified24In Brazil, low-income favelas have 5x higher crack use prevalence
Directional25U.S. adults 26+ had 11.2% past-month alcohol use disorder rate among heavy users
Single source26Elderly U.S. adults 65+ have rising benzodiazepine misuse at 2.6%
VerifiedDemographics Interpretation
This sobering constellation of data reveals that drug abuse is less a personal failing and more a societal fever chart, spiking predictably along the fractures of youth, poverty, discrimination, and trauma.
Economic Costs
1The economic cost of drug abuse in the U.S. was $740 billion annually in lost productivity, healthcare, and criminal justice
Verified2Opioid crisis cost U.S. states $1.02 trillion from 2017-2022 in economic burden
Verified3Global illicit drug trade valued at $650 billion in 2022
Verified4U.S. drug-related healthcare spending reached $85 billion in 2020
Directional5Lost workplace productivity from drug use disorders costs U.S. $249 billion yearly
Single source6Criminal justice costs for drug offenses in U.S. exceed $100 billion annually
Verified7In Europe, drug-related health damage costs €65 billion per year per EMCDDA 2022
Verified8U.S. premature deaths from drugs cost $1.02 trillion in 2017 alone in lost output
Verified9Methamphetamine production and trafficking generate $20-50 billion in U.S. underground economy yearly
Directional10Alcohol misuse costs U.S. economy $249 billion annually, overlapping with drug costs
Single source11Global treatment for drug use disorders costs only $3.5 billion yearly vs. $100 billion needed
Verified12Fentanyl crisis led to $1.5 trillion in U.S. economic losses projected over a decade
Verified13Drug-related absenteeism costs U.S. employers $84 billion per year
Verified14In Canada, opioid crisis economic burden was CAD 49 billion from 2016-2021
Directional15U.S. foster care costs rose 20% due to parental drug abuse, totaling $10 billion yearly
Single source16Drug trafficking fuels 20% of organized crime revenue globally, estimated at $130 billion
Verified17Emergency department visits for drugs cost U.S. Medicare $2.6 billion in 2011
Verified18In Australia, illicit drugs cost AUD 25.2 billion in 2015-16
Verified19U.S. drug courts save $4,000-$13,000 per participant in reduced incarceration costs
Directional20Homelessness linked to drug abuse costs U.S. cities $30,000 per person annually
Single source21Productivity losses from opioid use disorder averaged $11,000 per person yearly
Verified22Drug-related motor vehicle crashes cost U.S. $50 billion annually
Verified23In the UK, drug misuse societal costs were £19.3 billion in 2018/19
VerifiedEconomic Costs Interpretation
The staggering financial toll of drug abuse reveals a society hemorrhaging trillions from lost lives and productivity, while spending a comparative pittance to actually heal its people.
Health Consequences
1Drug overdose deaths in the U.S. reached 107,941 in 2022, a 4% increase from 2021
Verified2Opioids were involved in 81,806 overdose deaths in the U.S. in 2022
Verified3Fentanyl and synthetic opioids caused 73,838 deaths in the U.S. in 2022
Verified4Stimulant-involved overdose deaths rose to 33,663 in the U.S. in 2022, up 9% from prior year
Directional5In 2021, 36,469 cocaine-involved overdose deaths occurred in the U.S.
Single source6Methamphetamine-related overdose deaths increased 50-fold from 2012 to 2022 in the U.S., totaling over 36,000 in 2022
Verified7Heroin overdose deaths dropped to 13,315 in the U.S. in 2022 from higher peaks
Verified8Alcohol contributes to 178,000 deaths annually in the U.S., including from drug interactions
Verified9Cannabis use disorder affects 30% of marijuana users, leading to respiratory issues in 20-30% chronic users
Directional10Long-term opioid use leads to addiction in 8-12% of patients prescribed for chronic pain
Single source11Injecting drug use accounts for 10% of new HIV infections globally
Verified1235% of drug-related deaths worldwide involve multiple substances, per 2022 data
Verified13Chronic methamphetamine use causes brain dopamine system damage in 50-80% of heavy users
Verified14Cocaine use increases heart attack risk by 24 times within the first hour of use
Directional15Prescription sedative misuse linked to 13,486 overdose deaths in U.S. 2021
Single source16Neonatal abstinence syndrome affected 7 per 1,000 U.S. hospital births in 2017 due to prenatal opioid exposure
Verified17Heavy alcohol use causes liver cirrhosis in 20-30% of chronic drinkers over time
Verified18MDMA use associated with hyperthermia and serotonin syndrome in 15% of emergency visits
Verified19Inhalant abuse leads to sudden sniffing death syndrome in 5-15% of chronic users
Directional20Psychedelic use like LSD rarely causes direct overdose but 22% report persistent psychosis
Single source21Kratom-related calls to U.S. poison centers rose 62-fold from 2011-2021
Verified22Benzodiazepine overdoses tripled from 2002-2015, often with opioids
Verified23Chronic cannabis smoking impairs lung function similar to tobacco in 20% users
Verified24Opioid use disorder increases fracture risk by 2.3 times due to falls
Directional25Stimulant use linked to 27% increase in stroke risk among young adults
Single source26Alcohol-drug polydrug use accounts for 40% of fatal overdoses in Europe
VerifiedHealth Consequences Interpretation
Even as heroin retreats, the grim arithmetic of America's drug crisis keeps recalculating, with synthetic opioids writing the main tragedy and a chorus of other substances ensuring the death toll is a relentlessly rising sum of countless personal catastrophes.
Treatment
1In 2021, 2.0 million U.S. people aged 12+ received treatment for SUD at specialty facility
Verified2Only 10.4% of U.S. people with SUD received any treatment in 2021
Verified3Medication-assisted treatment (MAT) reached 1.2 million with OUD in U.S. 2021
Verified4Buprenorphine prescriptions for OUD increased 68% from 2018-2022 in U.S.
Directional5U.S. SUD treatment admissions for opioids were 45% of total in 2020
Single source6Retention in methadone treatment averages 50% at 6 months for OUD
Verified7Contingency management boosts stimulant abstinence by 50% in trials
Verified848% of U.S. adults in treatment relapsed within 1 year post-discharge 2021
Verified9Telehealth SUD treatment visits surged 60% during COVID-19 in U.S.
Directional10Global coverage of drug treatment is 1 in 7 people needing it
Single source11In Europe, 750,000 people in outpatient drug treatment in 2021 per EMCDDA
Verified12Naltrexone reduces opioid relapse by 50% in first 6 months per studies
Verified13Cognitive behavioral therapy success rate 40-60% for cocaine dependence
Verified14U.S. residential treatment completion rate averages 55% for all substances
Directional15Methadone clinics in U.S. treat 400,000 OUD patients annually
Single source1612-step programs like NA have 20-30% long-term abstinence rates
Verified17Harm reduction syringe programs reduced HIV transmission 50% in U.S. cities
Verified18Fentanyl test strip distribution increased safe use awareness by 70% in pilots
Verified19In Australia, opioid agonist therapy retention 70% at 12 months
Directional20U.S. adolescents in treatment 70% cited marijuana as primary drug 2020
Single source21Vivitrol (extended-release naltrexone) used by 20% of MAT patients in U.S.
VerifiedTreatment Interpretation
We are finally prescribing common sense and innovative treatments more widely, yet our collective war on drugs still resembles a neglected garden where we sprinkle water on a few thirsty plants while pretending we don't see the rest of the field withering away.
Usage Prevalence
1In 2021, approximately 70.4 million people aged 12 or older (25.0% of the U.S. population) used illicit drugs in the past year
Verified2Worldwide, an estimated 296 million people used drugs in 2021, which is 5.8% of the global adult population
Verified3In the United States, marijuana was the most commonly used illicit drug in 2022, with 18.7% of people aged 12+ reporting past-year use
Verified4About 48.7 million Americans aged 12 or older (17.3%) used marijuana in the past year as of 2021 data
Directional5In Europe, cannabis remains the most used drug, with 21.8 million young adults (15-34) having used it in the last year per 2022 EMCDDA data
Single source6Prescription opioid misuse affected 9.3 million people aged 12+ in the U.S. in 2021
Verified7Globally, 40 million people suffer from drug use disorders, representing 13% of those who use drugs
Verified8In 2022, 6.1 million U.S. adults misused prescription pain relievers in the past year
Verified9Amphetamine use reached 30 million past-year users globally in 2021
Directional10In the U.S., 2.7 million people aged 12+ had cocaine use disorder in 2021
Single source11Heroin use in the past year was reported by 828,000 Americans aged 12+ in 2021
Verified12Methamphetamine past-year use among U.S. adults aged 18+ was 2.5% in 2021
Verified13In Australia, 3.4 million people (16.4%) used illicit drugs in the past 12 months per 2022-2023 NDSHS
Verified14Lifetime ecstasy/MDMA use among U.S. young adults (18-25) was 10.5% in 2021
Directional15Inhalant past-year use was reported by 1.1 million U.S. adolescents aged 12-17 in 2021
Single source16Hallucinogen use in the past year affected 2.6 million U.S. people aged 12+ in 2021
Verified17In Canada, 21% of the population aged 15+ reported past-year cannabis use in 2022
Verified18Global past-year opioid use (excluding prescription misuse) was 60 million people in 2021
Verified19U.S. past-month binge alcohol use combined with illicit drugs was 5.3 million people aged 12+ in 2021
Directional20In the UK, 1 in 10 adults aged 16-59 used drugs in the last year per 2022 CSEW
Single source21LSD past-year use among U.S. adults was 0.9% in 2021
Verified22In Brazil, lifetime crack-cocaine use prevalence is 2.4% among adults
Verified23U.S. past-year tranquilizer/sedative misuse was 4.9 million people aged 12+ in 2021
Verified24Global cocaine use hit 22 million past-year users in 2021
Directional25Among U.S. high school seniors, 29.8% reported lifetime marijuana use in 2022
Single source26In South Africa, 15% of adults used cannabis in the past year per 2019 survey
Verified27U.S. past-year PCP use was 93,000 people aged 12+ in 2021
Verified28In Mexico, 11.6% of adults aged 12-65 used illicit drugs in the past year per 2016-2017 survey
Verified29Global past-year cannabis use was 219 million people in 2021
DirectionalUsage Prevalence Interpretation
These statistics paint a sobering, global portrait of self-medication, revealing that for every person seeking a chemical escape from reality, there's an unmet need—or a dangerous curiosity—lurking in the real world we've built.
Sources & References
- Reference 1SAMHSAsamhsa.govVisit source
- Reference 2UNODCunodc.orgVisit source
- Reference 3NIDAnida.nih.govVisit source
- Reference 4EMCDDAemcdda.europa.euVisit source
- Reference 5WHOwho.intVisit source
- Reference 6CDCcdc.govVisit source
- Reference 7AIHWaihw.gov.auVisit source
- Reference 8CANADAcanada.caVisit source
- Reference 9GOVgov.ukVisit source
- Reference 10NCBIncbi.nlm.nih.govVisit source
- Reference 11SAMRCsamrc.ac.zaVisit source
- Reference 12GOBgob.mxVisit source
- Reference 13NEJMnejm.orgVisit source
- Reference 14NIAAAniaaa.nih.govVisit source
- Reference 15JAMANETWORKjamanetwork.comVisit source
- Reference 16AHAJOURNALSahajournals.orgVisit source
- Reference 17ASCPascp.orgVisit source
- Reference 18OJPojp.govVisit source
- Reference 19DEAdea.govVisit source
- Reference 20BROOKINGSbrookings.eduVisit source
- Reference 21ACFacf.hhs.govVisit source
- Reference 22PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 23NCJRSncjrs.govVisit source
- Reference 24NLIHCnlihc.orgVisit source
- Reference 25NHTSAnhtsa.govVisit source